Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Major

Showing results (161-170 of 336) with videos related to

Pageof 34
Sort By:
British Journal of Cancer|March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancerC A Townsley, P Major, L L Siu, et al.
Nature Communications|April 29, 2018
Transporter gene acquisition and innovation in the evolution of Microsporidia intracellular parasitesP Dean, K M Sendra, T A Williams, et al.
Journal of Bone Oncology|February 25, 2016
Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trialsRobert E Coleman, Allan Lipton, Luis Costa, et al.
Journal of Cardiovascular Computed Tomography|March 31, 2015
Esmolol is noninferior to metoprolol in achieving a target heart rate of 65 beats/min in patients referred to coronary CT angiography: a randomized controlled clinical trialPál Maurovich-Horvat, Mihály Károlyi, Tamás Horváth, et al.
Investigational New Drugs|March 4, 2005
A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancerMary J Mackenzie, Holger W Hirte, Goss Glenwood, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 22, 2023
MicroRNA biomarkers for diagnosis of mild traumatic brain injury and prediction of persistent symptoms: A prospective cohort studyBiswadev Mitra, Brendan P Major, Jonathan Reyes, et al.
Frontiers in Microbiology|February 8, 2024
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancerLisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, et al.
Neurology|February 7, 2025
Next-Day Serum Glial Fibrillary Acidic Protein Levels to Aid Diagnosis of Sport-Related ConcussionWilliam T O'Brien, James W Hickey, Steven Mutimer, et al.
Biomarker Research|January 10, 2021
Prolonged elevation of serum neurofilament light after concussion in male Australian football playersStuart J McDonald, William T O'Brien, Georgia F Symons, et al.
Cytokine & Growth Factor Reviews|September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.
Pageof 34

Showing results (161-170 of 336) with videos related to

Sort By:
Pageof 34
British Journal of Cancer|March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancerC A Townsley, P Major, L L Siu, et al.
Nature Communications|April 29, 2018
Transporter gene acquisition and innovation in the evolution of Microsporidia intracellular parasitesP Dean, K M Sendra, T A Williams, et al.
Journal of Bone Oncology|February 25, 2016
Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trialsRobert E Coleman, Allan Lipton, Luis Costa, et al.
Journal of Cardiovascular Computed Tomography|March 31, 2015
Esmolol is noninferior to metoprolol in achieving a target heart rate of 65 beats/min in patients referred to coronary CT angiography: a randomized controlled clinical trialPál Maurovich-Horvat, Mihály Károlyi, Tamás Horváth, et al.
Investigational New Drugs|March 4, 2005
A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancerMary J Mackenzie, Holger W Hirte, Goss Glenwood, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 22, 2023
MicroRNA biomarkers for diagnosis of mild traumatic brain injury and prediction of persistent symptoms: A prospective cohort studyBiswadev Mitra, Brendan P Major, Jonathan Reyes, et al.
Frontiers in Microbiology|February 8, 2024
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancerLisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, et al.
Neurology|February 7, 2025
Next-Day Serum Glial Fibrillary Acidic Protein Levels to Aid Diagnosis of Sport-Related ConcussionWilliam T O'Brien, James W Hickey, Steven Mutimer, et al.
Biomarker Research|January 10, 2021
Prolonged elevation of serum neurofilament light after concussion in male Australian football playersStuart J McDonald, William T O'Brien, Georgia F Symons, et al.
Cytokine & Growth Factor Reviews|September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.
Pageof 34